Commvault Systems Inc vs Sanofi SA — how do they compare? Commvault Systems Inc trades at $151.05 (market cap $5.87B), while Sanofi SA trades at $43.81 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 17.8× Commvault Systems Inc's market cap, and Sanofi SA pays a 5.53% dividend while Commvault Systems Inc pays none. Which is the better fit depends on your goals.
| CVLT | SNY | |
|---|---|---|
Market Cap | $5.87B | $104.30B |
Sector | Technology | Health |
52-Week High | $195.41 | $52.34 |
52-Week Low | $75.18 | $41.33 |
Enterprise Value | $5.86B | $124.19B |
Dividend Yield | — | 5.53% |
Trailing returns across standard periods
Latest headlines on both assets
Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →